Biomarker Discovery

biomarker discovery

Our innovative Biomarker Discovery program makes us a preferred partner for our pharmaceutical clients looking to identify novel targets for targeted therapies in pre-clinical development.

We have a long history of partnering with pharmaceutical companies to improve the clinical development process through discovery of novel markers and validation in tumor samples and cell lines.

We focus on:

  • Biomarker discovery for drugs in development, looking for:

  • Predictive biomarkers: drug response / intent to treat

  • Prognostic biomarkers: natural history of the disease

In-house and through partnerships we perform comprehensive pathology, molecular biology, in vitro and in vivo techniques:

  • Mutation analysis in tumor tissue and blood

  • Gene amplification and translocation testing

  • Immunohistochemistry (IHC)

  • Gene expression

  • MTT proliferation assays

  • Western blotting

  • Colony formation, migration and invasion assays

  • Molecular profiling of cell lines and tissue samples

  • Gene silencing

We have the capacity to work with formalin-fixed paraffin-embedded tumor tissue, fresh frozen samples, serum, plasma, platelets, and cytologies.
For further details of our biomarker discovery services: Contact us


We use first and third party cookies to track your browsing habits on our website in order to provide you with better quality and security, and improve the services offered through this website. If users do not explicitly confirm that they consent to the installation of cookies but continue to browse our website, we will assume that they have agreed and we will inform them accordingly about the possibility of blocking or deleting any previously installed cookies by adjusting their browser settings. You can find out more about cookies in our "Cookie Policy".